Reprints Available Upon Request
Selected Publications
Hays, S.M., L.L. Aylward, B.C. Blount. 2015. Variation in urinary flow rates according to demographic characteristics and body mass index in NHANES: Potential confounding of associations between health outcomes and urinary biomarker concentrations. Environ. Health Perspect. 123:293–300.
Sweeney LM, Kester JE, Kirman, C.R. 2015. Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4). Crit Rev Toxicol. 2015 May 21:1-65.
Bus JS, Banton MI, Faber WD, Kirman CR, McGregor DB, Pourreau DB. 2015. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations. Crit Rev Toxicol. 45(2):142-71.
St-Amand, A., K. Werry, L.L. Aylward, S.M. Hays, A. Nong. 2014. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context. Toxicol. Letters. 231(2):126-34.
Koch, H.M., L.L. Aylward, S.M. Hays, R. Smolders, R. Moos, J. Cocker, K. Jones, N. Warren, L. Levy, R. Bevan. 2014. Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: Personal care product ingredients. Toxicol Letters. 231(2):261-9.
Saravanabhavan, G., M. Walker, M. Guay, L.L. Aylward. 2014. Urinary excretion and daily intake rates of diethyl phthalate in the general Canadian population. Science Total Environ. 500-501:191-8.
Becker, R.A., S.M. Hays, C.R. Kirman, L.L. Aylward, and K. Wise. 2014. Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens. Birth Defects Research Part B: Developmental and Reproductive Toxicology. 101(1):114-24. Voted one the 10 Best Papers in 2014 by the Risk Assessment Specialty Section of the Society of Toxicology.
Aylward LL, Ramasamy S, Hays SM, Schoeny R, Kirman CR. 2014. Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposure. Regul Toxicol Pharmacol. 69(1):49-54.
Ball N, Bartels M, Budinsky R, Klapacz J, Hays S, Kirman C, Patlewicz G. 2014. The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study. Regul Toxicol Pharmacol. 68(2):212-21.
Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays SM, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol. 34(5):525-36.
Aylward, L.L., C.R. Kirman, R. Schoeny, C.J. Portier, S.M. Hays. 2013. Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: Perspectives across chemicals. Environ Health Persp. 121:287-294. Voted one the 10 Best Papers in 2013 by the Risk Assessment Specialty Section of the Society of Toxicology.
Kirman, C.R., L.L. Aylward, M. Suh, M.A. Harris, C.M. Thompson, L.C. Haws, D.M. Proctor, S.S. Lin, W. Parker, S.M. Hays. 2013. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chemico-Biological Int. 204:13-27
Boogaard PJ, Aylward LL, Hays SM. 2012. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH. Int J Hyg Environ Health. 215(2):238-41. Voted one the 10 Best Papers in 2011 by the Risk Assessment Specialty Section of the Society of Toxicology.
Hays, S., Pyatt, D.W., Kirman, C., Aylward, L. 2012. Biomonitoring Equivalents for Benzene. Regulatory Toxicology and Pharmacology, V62(1), p. 62-73. Voted one the 10 Best Papers in 2012 by the Risk Assessment Specialty Section of the Society of Toxicology.
Kirman, C., Aylward, L., Blount, B., Pyatt, D. Hays, S. 2012 Evaluation of NHANES Biomonitoring Data for Volatile Organic Chemicals in Blood-Application of Chemical Specific Screening Criteria. J Exp Sci Environ Epidemiol, 22(1):24-35.
Proctor DM, Suh M, Aylward LL, Kirman CR, Harris MA, Thompson CM, Gürleyük H, Gerads R, Haws LC, Hays SM. 2012. Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere. 89(5):487-93.
Aylward LL, Kirman CR, Adgate JL, McKenzie LM, Hays SM. 2012 Interpreting variability in population biomonitoring data: role of elimination kinetics. J
Expo Sci Environ Epidemiol. 22(4):398-408.
Angerer J, Aylward LL, Hays SM, Heinzow B, Wilhelm M. 2011. Human biomonitoring assessment values: approaches and data requirements. Int J Hyg Environ Health. 214(5):348-60.
Aylward, L.L., C.R. Kirman, B.C. Blount, S.M. Hays. 2010. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs) - Application of steady-state PBPK model solutions. Reg. Toxicol. Pharmacol. 58(1):33-44. Voted one the 10 Best Papers in 2010 by the Risk Assessment Specialty Section of the Society of Toxicology.
Simon, T., L. Aylward, C.R. Kirman, C. Rowlands, R. Budinsky 2009. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin using linear and non-linear dose-response modeling and toxicokinetics. Toxicol. Sci. 112(2):490-506. Voted one the 10 Best Papers in 2009 by the Risk Assessment Specialty Section of the Society of Toxicology.
Sweeney LM, Kester JE, Kirman, C.R. 2015. Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4). Crit Rev Toxicol. 2015 May 21:1-65.
Bus JS, Banton MI, Faber WD, Kirman CR, McGregor DB, Pourreau DB. 2015. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations. Crit Rev Toxicol. 45(2):142-71.
St-Amand, A., K. Werry, L.L. Aylward, S.M. Hays, A. Nong. 2014. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context. Toxicol. Letters. 231(2):126-34.
Koch, H.M., L.L. Aylward, S.M. Hays, R. Smolders, R. Moos, J. Cocker, K. Jones, N. Warren, L. Levy, R. Bevan. 2014. Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: Personal care product ingredients. Toxicol Letters. 231(2):261-9.
Saravanabhavan, G., M. Walker, M. Guay, L.L. Aylward. 2014. Urinary excretion and daily intake rates of diethyl phthalate in the general Canadian population. Science Total Environ. 500-501:191-8.
Becker, R.A., S.M. Hays, C.R. Kirman, L.L. Aylward, and K. Wise. 2014. Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens. Birth Defects Research Part B: Developmental and Reproductive Toxicology. 101(1):114-24. Voted one the 10 Best Papers in 2014 by the Risk Assessment Specialty Section of the Society of Toxicology.
Aylward LL, Ramasamy S, Hays SM, Schoeny R, Kirman CR. 2014. Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposure. Regul Toxicol Pharmacol. 69(1):49-54.
Ball N, Bartels M, Budinsky R, Klapacz J, Hays S, Kirman C, Patlewicz G. 2014. The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study. Regul Toxicol Pharmacol. 68(2):212-21.
Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays SM, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol. 34(5):525-36.
Aylward, L.L., C.R. Kirman, R. Schoeny, C.J. Portier, S.M. Hays. 2013. Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: Perspectives across chemicals. Environ Health Persp. 121:287-294. Voted one the 10 Best Papers in 2013 by the Risk Assessment Specialty Section of the Society of Toxicology.
Kirman, C.R., L.L. Aylward, M. Suh, M.A. Harris, C.M. Thompson, L.C. Haws, D.M. Proctor, S.S. Lin, W. Parker, S.M. Hays. 2013. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chemico-Biological Int. 204:13-27
Boogaard PJ, Aylward LL, Hays SM. 2012. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH. Int J Hyg Environ Health. 215(2):238-41. Voted one the 10 Best Papers in 2011 by the Risk Assessment Specialty Section of the Society of Toxicology.
Hays, S., Pyatt, D.W., Kirman, C., Aylward, L. 2012. Biomonitoring Equivalents for Benzene. Regulatory Toxicology and Pharmacology, V62(1), p. 62-73. Voted one the 10 Best Papers in 2012 by the Risk Assessment Specialty Section of the Society of Toxicology.
Kirman, C., Aylward, L., Blount, B., Pyatt, D. Hays, S. 2012 Evaluation of NHANES Biomonitoring Data for Volatile Organic Chemicals in Blood-Application of Chemical Specific Screening Criteria. J Exp Sci Environ Epidemiol, 22(1):24-35.
Proctor DM, Suh M, Aylward LL, Kirman CR, Harris MA, Thompson CM, Gürleyük H, Gerads R, Haws LC, Hays SM. 2012. Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere. 89(5):487-93.
Aylward LL, Kirman CR, Adgate JL, McKenzie LM, Hays SM. 2012 Interpreting variability in population biomonitoring data: role of elimination kinetics. J
Expo Sci Environ Epidemiol. 22(4):398-408.
Angerer J, Aylward LL, Hays SM, Heinzow B, Wilhelm M. 2011. Human biomonitoring assessment values: approaches and data requirements. Int J Hyg Environ Health. 214(5):348-60.
Aylward, L.L., C.R. Kirman, B.C. Blount, S.M. Hays. 2010. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs) - Application of steady-state PBPK model solutions. Reg. Toxicol. Pharmacol. 58(1):33-44. Voted one the 10 Best Papers in 2010 by the Risk Assessment Specialty Section of the Society of Toxicology.
Simon, T., L. Aylward, C.R. Kirman, C. Rowlands, R. Budinsky 2009. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin using linear and non-linear dose-response modeling and toxicokinetics. Toxicol. Sci. 112(2):490-506. Voted one the 10 Best Papers in 2009 by the Risk Assessment Specialty Section of the Society of Toxicology.